EDI048

EDI048 (compound 1.16) is an orally active Cryptosporidium PI4K inhibitor for the research of cryptosporidiosis[1].

Product Specifications

CAS Number

[2767264-57-1]

UNSPSC

12352005

Target

Parasite; PI4K

Type

Reference compound

Related Pathways

Anti-infection; PI3K/Akt/mTOR

Applications

COVID-19-immunoregulation

Field of Research

Infection

Assay Protocol

https://www.medchemexpress.com/edi048.html

Purity

99.86

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

O=C(C1=CC(N(C)C(C2=CC3=C(C4=CC=C(C(NC)=O)C=C4)C=NN3C=C2)=O)=CC=C1Cl)OC

Molecular Formula

C25H21ClN4O4

Molecular Weight

476.91

References & Citations

[1]Joseph Michael Young, et al. Compounds and compositions for the treatment of cryptosporidiosis. Patent US20220112189A1.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Scientific Category

Reference compound1

Clinical Information

Phase 1

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

NBP3-26962IR 0.1 mL

Mouse Monoclonal Stathmin 1 Antibody (STMN1/8438) [DyLight 755]

Ask

View Details

MBS3243510-01 0.1 mg

LRRC37A2 Peptide - C-terminal region

Ask

View Details

MBS3243510-02 5x 0.1 mg

LRRC37A2 Peptide - C-terminal region

Ask

View Details

Z03729-1 1 mg

SARS-CoV-2 Spike protein S1, Omicron Variant, His Tag

Ask

View Details

SL1864Hu-01 48 Tests

Human α-sarcomeric actin, α-SCA ELISA Kit

Ask

View Details

SL1864Hu-02 96 Tests

Human α-sarcomeric actin, α-SCA ELISA Kit

Ask

View Details